Precision nephrotoxicity testing using 3D in vitro models
P Yu, H Zhu, CC Bosholm, D Beiner, Z Duan… - Cell & Bioscience, 2023 - Springer
Nephrotoxicity is a significant concern during the development of new drugs or when
assessing the safety of chemicals in consumer products. Traditional methods for testing …
assessing the safety of chemicals in consumer products. Traditional methods for testing …
In silico prediction of drug-induced nephrotoxicity: current progress and pitfalls
N Li, J Shi, Z Chen, Z Dong, S Ma, Y Li… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Due to its role in absorption and metabolism, the kidney is an important target
for drug toxicity. Drug-induced nephrotoxicity (DIN) presents a significant challenge in …
for drug toxicity. Drug-induced nephrotoxicity (DIN) presents a significant challenge in …
Delineation of the molecular mechanisms underlying Colistin-mediated toxicity using metabolomic and transcriptomic analyses
The mechanisms underlying colistin-induced toxicity are not fully understood. This study
used untargeted metabolomics and transcriptomics to elucidate the molecular processes …
used untargeted metabolomics and transcriptomics to elucidate the molecular processes …
Using intracellular metabolic profiling to identify novel biomarkers of cisplatin-induced acute kidney injury in NRK-52E cells
HR Kim, JH Park, SH Lee, SJ Kwack, J Lee… - Journal of Toxicology …, 2022 - Taylor & Francis
The aim of this study was to investigate changes in the intracellular metabolism resulting
from cisplatin (CDDP)-induced nephrotoxicity in normal kidney tubular epithelial NRK-52E …
from cisplatin (CDDP)-induced nephrotoxicity in normal kidney tubular epithelial NRK-52E …
Evidence of synergistic mechanisms of hepatoprotective botanical herbal preparation of Pueraria montana var. lobata and Schisandra sphenanthera
Y Lv, H Li, BT Zhai, J Sun, JX Cheng… - Frontiers in …, 2024 - frontiersin.org
Background Pueraria montana var. lobata (Willd.) Maesen & SM Almeida ex Sanjappa &
Predeep (syn. Pueraria lobata (Willd.) Ohwi) and Schisandra sphenanthera Rehder & EH …
Predeep (syn. Pueraria lobata (Willd.) Ohwi) and Schisandra sphenanthera Rehder & EH …
Cullin-3 proteins be a novel biomarkers and therapeutic targets for hyperchloremia induced by oral poisoning
H Duan, N Li, J Qi, X Li, K Zhou - Scientific Reports, 2024 - nature.com
Oral poisoning can trigger diverse physiological reactions, determined by the toxic
substance involved. One such consequence is hyperchloremia, characterized by an …
substance involved. One such consequence is hyperchloremia, characterized by an …
Platinum-based chemotherapies-induced nephrotoxicity: mechanisms, potential treatments, and management
F Shahrahmani, S Badamchizadeh, F Kaihani… - … Urology and Nephrology, 2024 - Springer
Platinum-based chemotherapies are essential in the treatment of several malignancies.
However, such medications can damage the kidneys, frequently leading to both acute and …
However, such medications can damage the kidneys, frequently leading to both acute and …
Systems approaches to cell culture-derived extracellular vesicles for acute kidney injury therapy: Prospects and challenges
DJ Lundy, B Szomolay, CT Liao - Function, 2024 - academic.oup.com
Acute kidney injury (AKI) is a heterogeneous syndrome, comprising diverse etiologies of
kidney insults that result in high mortality and morbidity if not well managed. Although great …
kidney insults that result in high mortality and morbidity if not well managed. Although great …
[HTML][HTML] Omics and Artificial Intelligence in Kidney Diseases
N Grobe, J Scheiber, H Zhang, C Garbe… - Advances in Kidney …, 2023 - Elsevier
Omics applications in nephrology may have relevance in the future to improve clinical care
of kidney disease patients. In a short term, patients will benefit from specific measurement …
of kidney disease patients. In a short term, patients will benefit from specific measurement …
Surufatinib-induced renal thrombotic microangiopathy: first case report and review of literature
W Zhu, W Wang, Y Shi, B Shen, Y Li - Virchows Archiv, 2023 - Springer
Angiogenesis inhibitors such as tyrosine kinase inhibitors (TKIs) are common therapeutics
currently used to treat oncologic disease. Surufatinib is a novel, small-molecule multiple …
currently used to treat oncologic disease. Surufatinib is a novel, small-molecule multiple …